AI Generated Image
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
KOLN | Nebraska Local News, Weather, Sports | Lincoln, NE • • business
Key Points:
- Breckenridge Pharmaceutical recalled nearly 360,000 bottles of the antidepressant duloxetine due to high levels of nitrosamines, a chemical that may increase cancer risk.
- The recall affects duloxetine delayed-release capsules in 30-mg and 60-mg sizes, with specific lot codes and expiration dates ranging from November 2026 to May 2027.
- The recalled medication was distributed nationwide, prompting the FDA to advise patients to consult their doctors or pharmacists for guidance.
- Medical experts caution against stopping the medication without professional consultation to ensure patient safety.
